 Chagas disease is caused by the protozoan parasite trapanosoma cruzi. Benznitazole is currently the only drug approved for treating Chagas disease, but it can cause serious side effects and resistance to the drug has been reported. Our research team has identified two new amino pyridine derivatives, cis, aquaticloro, N-4-hydroxyphenyl, methyl, D2, pyridine methamino, copper, 3A, and its glycosylated lig and cystichloro, N-4-2-3-4-6-tetra-O, acetyl-beta-deglucopyronosyloxy, phenyl, methyl, D2, pyridine methamino, copper, 3B, which have shown promise in treating Chagas disease. These compounds have been found to be effective at killing the parasites, while also being non-toxic to human cells. Additionally, they have been found to inhibit the association between the parasites and host cells, suggesting that they could be used to prevent transmission of the disease. This article was authored by Raffaella Silva Oliveira, Leandro S. Sanjanito, Andrew Reddy, and others. We are article.tv, links in the description below.